ALDX

Aldeyra Therapeutics Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 0/10
  • Momentum↑ 6/10
Aldeyra Therapeutics sales and earnings growth
ALDX Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ 2.67%
  • FCF Y/Y↓ -30.69%
Aldeyra Therapeutics gross and profit margin trends
ALDX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -130.90%
Aldeyra Therapeutics net debt vs free cash flow
ALDX Risk
Great
  • Debt / Equity↓ 0.3
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -21.7

Aldeyra Therapeutics stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗